RxDoctor Payments Data

James Carroll, MD

Family Medicine · Bakersville, NCNPI 1225060148

Payments from drug & device makers

$547in general payments, 2019–2025

Across 34 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$221
  • AbbVie$90
  • Johnson & Johnson$43
  • Indivior Inc.$41
  • Lilly USA, LLC$29
  • Takeda Pharmaceuticals U.S.A., Inc.$29
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,550
Medicare patients
53
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban95$87,083
JardianceEmpagliflozin66$81,168
OzempicSemaglutide67$68,417
EliquisApixaban55$51,424
XifaxanRifaximin11$33,787
Tresiba Flextouch U-200Insulin Degludec23$29,808
TrulicityDulaglutide31$28,482
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$19,593
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl97$12,231
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$11,372
LinzessLinaclotide21$10,628
EntrestoSacubitril/Valsartan14$8,870
BrilintaTicagrelor14$6,945
Insulin Lispro Kwikpen U-100Insulin Lispro16$4,842
Dexlansoprazole DrDexlansoprazole19$3,896

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$43$87,08395 claims
Novo NordiskOzempic$221$68,41767 claims
PfizerEliquis$14$51,42455 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta$14$34,03561 claims
Lilly USA, LLCTrulicity, Humalog$29$31,62756 claims
AbbVieLinzess, Synthroid$90$11,71636 claims
NovartisEntresto$15$8,87014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Bakersville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →